美国生物技术公司Metsera涨幅扩大至12.6%
Ge Long Hui A P P·2025-11-04 15:17
Group 1 - The core point of the article is that the American biotechnology company Metsera has resumed trading, with its stock price increasing by 12.6% [1]
Group 1 - The core point of the article is that the American biotechnology company Metsera has resumed trading, with its stock price increasing by 12.6% [1]